HOROWITZ ZEBULUN D 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Feb 5, 2008
Insider Transaction Report
Form 4
HOROWITZ ZEBULUN D
SVP - Chief Medical Officer
Transactions
- Exercise/Conversion
Option to Purchase Common Stock, $.01 par value
2008-02-01$2.52/sh−5,000$12,600→ 0 totalExercise: $2.52From: 2004-03-24Exp: 2013-03-24→ Common Stock, $.01 par value per share (5,000 underlying) - Exercise/Conversion
Common Stock, $.01 par value per share
2008-02-04$4.31/sh+5,000$21,550→ 138,078 total - Exercise/Conversion
Common Stock, $.01 par value per share
2008-02-01$2.52/sh+5,000$12,600→ 138,078 total - Sale
Common Stock, $.01 par value per share
2008-02-04$19.86/sh−5,000$99,306→ 133,078 total - Sale
Common Stock, $.01 par value per share
2008-02-01$19.56/sh−5,000$97,791→ 133,078 total - Exercise/Conversion
Option to Purchase Common Stock, $.01 par value
2008-02-04$4.31/sh−5,000$21,550→ 70,000 totalExercise: $4.31From: 2005-02-17Exp: 2014-02-17→ Common Stock, $.01 par value per share (5,000 underlying)
Footnotes (3)
- [F1]This sale was made pursuant to a trading plan adopted on June 14, 2007 by the reporting person in accordance with Rule 105b-1 under the Securities Exchange Act of 1934.
- [F2]Represents the average sale price. The highest price at which shares were sold was $19.97 and the lowest price at which shares were sold was $19.05.
- [F3]Represents the average sale price. The highest price at which shares were sold was $20.03 and the lowest price at which shares were sold was $19.995.